US FDA grants orphan Drug and rare pediatric disease designations to GEn1E lifesciences’ dual signal modulator for the treatment of Duchenne Muscular Dystrophy Business Wire (Press Release) 10h Business Wire (Press Release) 10h
Top biotech gainers: Tngx hits new high, alvo moves closer to FDA approval, zvra, idya turn heads RTT News 18h RTT News 18h
Gmj Technologies Appoints Carol Berry, MBA as New Chief Executive Officer PR Newswire (Press Release) 20:59
GSK to buy Cambridge-based Nuvalent, maker of targeted cancer drugs, for $10.6 billion Boston Globe 18:58 Article paywall